Companies›Commodities›Chemicals›Chemicals & Petrochemicals
NSE:ARVEE

ARVEE LABORATORIES I LTD

Chemicals › Chemicals & Petrochemicals
₹187.50
at close · 28 Oct 2026
▲ 7.74 (+4.31%)

Latest filings

Next results: Tue, 3 Nov · Financial Results/Other business matters
  1. Arvee Labs fined about Rs 11,800 by NSE for late Reg 44 filing · Regulatory & Legal
  2. Arvee Labs AGM 2026 results: all 4 resolutions passed with 100 percent approval · Compliance
  3. Arvee Labs holds 14th AGM; financials adopted, directors re-appointed · Board & Shareholder Meetings
All filings ↓
Ask Nexa about ARVEE LABORATORIES I LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Makes and sells chemical products through its Non-Textile Segment, which generated ₹27.58 crore in FY26, or 85.7% of segment revenue. The smaller Textile Segment contributed ₹4.62 crore, or 14.3% of segment revenue, in the same period. For FY26 as a whole, the company reported total income of ₹3,219.52 lakhs, down from ₹3,914.45 lakhs in the prior year, while profit after tax rose to ₹252.63 lakhs from ₹214.74 lakhs on lower raw material consumption. Raw materials are the dominant cost, accounting for 57.7% of revenue, followed by other operating expenses at 29.1% and employee costs at 14.2%. The Non-Textile Segment was also the more profitable, with EBIT of ₹2.20 crore versus ₹0.38 crore in the Textile Segment. The business is small-scale, with total assets of ₹43.26 crore at FY26 and operations based in Ahmedabad, Gujarat.

Revenue mix · reported segments
Non-Textile Segment (Chemicals)85.7%
Textile Segment14.3%
Biggest cost
Raw materials consumed, at 57.7% of revenue
Kind of business
Small-scale specialty chemicals maker with a secondary textile business
Where it sits
Classified under Specialty Chemicals on NSE; FY26 revenue ₹31.51 crore
Market Cap
₹207 Cr
P / E (TTM)
51.0×
EV / EBITDA
34.3×
Div Yield
—
Growth
-7.8%▼
Revenue 5y CAGR
PAT -1.2% · EBITDA -10.2%
Quality
7.5%·
ROCE (FY26)
ROE 7.5% · margin 12.3%
Leverage
0.03·
Debt / Equity · low
Net debt ₹0.67 Cr
Revenue FY21→FY26
0.7×▼
Margin +2.4 pts
₹47 Cr → ₹32 Cr
Cash conversion
1.04×▲
Operating cash ÷ profit · 5 yrs
₹13 Cr on ₹12 Cr
Moves on a normal day
2.10%·
Median daily move
Last 264 sessions · the yardstick for filing-day moves
Where it sits among 107 Specialty Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#76/99
P/B#83/99
ROCE#66/106
ROE#55/99
Debt / Equity#29/99
EBITDA margin#50/99
Revenue growth#5/94
Profit growth#4/92

Scorecard

Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice

Strengths
Debt at 0.03× equity
lower than 71% of its 99 Specialty Chemicals peers
Over 5 years it reported ₹12 Cr of profit and ₹13 Cr of operating cash — 1.04×
Profit is converting into cash
Concerns
Revenue shrinking over 5 years (−8% a year)
Profit shrinking over 5 years (−1% a year)
Heavy working capital — 154 days of cash tied up

Charts

How has the market priced it — with filings on the timeline?

ARVEE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ARVEE LABORATORIES I LTD's filed financials and exchange disclosures

What does ARVEE LABORATORIES I LTD do?

ARVEE LABORATORIES I LTD is a Chemicals & Petrochemicals company listed on NSE, trading under the symbol ARVEE.

Is ARVEE LABORATORIES I LTD profitable?

Yes. Over the trailing twelve months ARVEE LABORATORIES I LTD reported a net profit of ₹4.05 Cr on revenue of ₹41 Cr.

Does ARVEE LABORATORIES I LTD pay a dividend?

Not in the latest reported year — ARVEE LABORATORIES I LTD's dividend payout for FY26 was nil.

Is ARVEE LABORATORIES I LTD debt-free?

No. It reported borrowings of ₹1.11 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹0.67 Cr after cash. Debt stands at 0.03× equity. That is lower than 71% of its 99 Specialty Chemicals peers.

Is ARVEE LABORATORIES I LTD expensive compared with its peers?

On trailing P/E, ARVEE LABORATORIES I LTD ranks 76 of 99 in Specialty Chemicals — cheaper than 24% of them, against an industry median of 23.1×. This is a position, not a valuation judgement.

How much does the ARVEE LABORATORIES I LTD share price move in a day?

On a typical session ARVEE LABORATORIES I LTD moves 2.10% — that is the median absolute close-to-close move across its last 264 trading days. MarketPing measures each filing's price reaction against it.

When are ARVEE LABORATORIES I LTD's next results?

Financial Results/Other business matters on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track ARVEE LABORATORIES I LTD's announcements?

Every NSE and BSE filing by ARVEE LABORATORIES I LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.